Clinical Trials Directory

Trials / Unknown

UnknownNCT04918849

WhatsApp in India During the COVID-19 Pandemic

Characterising the Spread of COVID-19 Misinformation Through WhatsApp in India

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Yale-NUS College · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

Digital misinformation has been flagged as a major risk of the 21st century, with an estimated cost of $78 billion to the global economy each year. Given this scope, we propose to characterize how misinformation is spread via messenger platforms (e.g. WhatsApp). Specifically, we seek to: 1. Identify metrics of potential misinformation (Aim 1). This is based on the hypothesis that although message contents are highly private, proxy markers can be used to identify potential misinformation. 2. Understand the base-rate by which misinformation is shared via messaging applications (Aim 2). This is founded on the hypothesis that misinformation is endemic on messaging platforms, and thus needs to be documented. 3. Identify "super spreaders" responsible for sending and receiving a large volume of misinformation (Aim 3). Here, we hypothesise that a small group of super spreaders are responsible for the bulk of misinformation-sharing on messaging applications. The thrust of this work aligns with both government priorities and the grant's thematic areas, providing actionable findings that are timely amidst a worldwide surge of misinformation.

Conditions

Timeline

Start date
2021-05-21
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2021-06-09
Last updated
2021-06-09

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT04918849. Inclusion in this directory is not an endorsement.